Jefferies initiates Compass Gas at “buy” with 38% upside on Brazil gas market refo

Jefferies initiated Compass Gas e Energia at Buy with a 37 reais price target, implying 38% upside from 26.85 reais and valuing the stock at 7.7x 2026 EV/EBITDA versus 6.4x currently. The broker highlighted 2026 revenue of 17.46 billion reais, EBITDA of 5.07 billion reais, and a strong FCF profile, while flagging concession renewals in 2027-2029 as a key catalyst. The note is supportive for the stock but appears to be an analyst initiation rather than a company event.

Analysis

The clean read-through is not just a stock call on a Brazilian utility platform; it is a sign that regulated midstream cash flows are re-rating as quasi-bond proxies with embedded option value on liberalization. The market is still pricing Compass like a stable, low-growth utility, but the mix matters: a dominant regulated anchor plus smaller renewables/adjoining infrastructure assets creates a path to multiple expansion if management keeps converting “growth” into FCF rather than balance-sheet expansion. That makes CSAN’s exposure materially more interesting than a headline stake in a gas distributor suggests, because the hidden asset is not EBITDA growth alone but the durability of distributable cash across rate cycles.

The second-order winner is anyone levered to Brazilian utility scarcity value, not the company with the highest near-term growth. If Compass can keep Comgás’ tariff framework intact while renewing the 2027-29 concessions, the market should start valuing the whole complex against regulated utilities rather than mixed industrial infrastructure, which is a meaningful spread compression opportunity. The key nuance is that the Street’s upside case is less about volume acceleration and more about the market acknowledging that the downside is already well protected by tariff mechanics and pass-throughs.

Risk is concentrated in the 6-12 month window around renewal and capex discipline, not day-to-day commodity moves. Any regulatory dilution in renewal terms, a higher-than-expected capex burden in Edge/biomethane, or evidence that FCF conversion remains below guidance would quickly cap the rerating. The contrarian angle is that the stock may be cheap for a reason: if investors believe the market is granting too much value to long-dated concessions and too little to near-term leverage, the equity can underperform even while the underlying business improves.

For CSAN, the market is likely underpricing the convexity from a cleaner Compass valuation because holdings-level opacity keeps the discount in place. That discount should narrow only if Compass continues to print through the next two reporting cycles and management demonstrates that the non-regulated portfolio is not a capital sink. In that sense, the best catalyst is not macro or gas prices; it is a sequence of boring but decisive quarterly confirmations that free cash flow is resilient and renewal risk is manageable.

Key Decisions for Investors

• Long CSAN over a 3-6 month horizon: target a 15-20% rerating if Compass continues to validate FCF conversion and concession-renewal risk stays contained; stop if updated filings show leverage or capex drifting materially above plan.
• Pair trade: long CSAN / short a Brazilian industrial cyclicals basket for 6-12 months, betting the market rewards regulated cash generation more than economically sensitive EBITDA; risk/reward improves if Brazilian rates stay elevated.
• If liquid enough, buy 6-12 month upside exposure in CSAN via calls rather than stock: the valuation gap is a rerating story, so options capture convexity while limiting downside if renewals disappoint.
• For a cleaner relative-value expression, long Brazilian utilities with regulated WACC visibility versus higher-beta infrastructure names that rely on growth capex; expect the spread to tighten over the next two earnings prints.